AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00964288 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Lidocaine
Description: positive control
Study NCT00964288 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: GSK1014802 high dose
Description: oral tablet
Study NCT00964288 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: To match GSK drug and positive control
Study NCT04551820 — intervention group
Intervention type: PROCEDURE
Intervention: Regular Hours
Description: The regular hours cohort includes cholecystectomies performed during the day shift at the Institution during Monday through Friday, not inclusive of national holidays.
Study NCT04551820 — intervention group
Intervention type: PROCEDURE
Intervention: After Hours
Description: The after hours cohort includes cholecystectomies performed outside of the day shift at the Institution during Monday through Friday, on the weekend, or during a national holiday.
Study NCT04551820 — intervention group
Intervention type: DEVICE
Intervention: Robotic-assisted Cholecystectomy
Description: With the patient under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and the da Vinci Robotic Surgical System (Intuitive) is docked to the patient and used to complete the cholecystectomy according to the surgeon's standard of care.
Study NCT02062801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ephedrine
Description: Patients received additional doses of ephedrine 10mg IV to a maximum of 30mg if BP remained low (\<90mmHg systolic) and/was associated with persistent fetal bradycardia or maternal symptoms of dizziness and nausea
Study NCT02062801 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients received normal saline (placebo) administered immediately after combined spinal epidural (CSE) placement
Study NCT01049412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LY2605541
Description: Administered subcutaneously every morning with dose titration based on blood glucose measures for 8 weeks in each of 2 study periods.
Study NCT01049412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2605541
Description: Administered subcutaneously every morning with dose titration based on blood glucose measures for 8 weeks in each of 2 study periods.
Study NCT01049412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin glargine
Description: Administered subcutaneously every morning with dose titration based on blood glucose measures for 8 weeks in each of 2 study periods.
Study NCT01049412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Description: Administered subcutaneously every morning with dose titration based on blood glucose measures for 8 weeks in each of 2 study periods.
Study NCT05878379 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary Iron Program
Description: Teachers Lesson 1: Discuss about causes, prevention and effects of anemia and ID, dietary iron, dietary enhancers and inhibitors of iron absorption, and school lunch menu Lesson 2: Participate in and observe how to teach children in an iron curriculum~Caregivers Lesson 1: Presentation and group talk about causes, prevention, and effects of anemia and ID, dietary iron, and dietary enhancers and inhibitors of iron absorption Lesson 2: Discuss benefits and barriers of changing to an iron-rich meal at home Lesson 3: Cooking class for preparing an iron-rich meal at home (2 times) Lesson 4: Home visit~Children Lesson 1: Group talk about causes and effects of anemia and ID Games: Where are you from? Lesson 2: Presentation and group talk about dietary iron, and dietary enhancers and inhibitors of iron absorption, and iron-rich food Games: What is the winner? Assignment: Market assignment Lesson 3: Cooking class (2 times)
Study NCT01820858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175 mg/m(2), intravenously (IV)
Study NCT01820858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paraplatin (Carboplatin Injection)
Description: AUC=5, IV
Study NCT01820858 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic Radiation
Description: 45-50 Gy
Study NCT01820858 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal Brachytherapy 1
Description: 5 Gy, 3 times
Study NCT01820858 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal brachytherapy 2
Description: 5 Gy, 2-4 times
Study NCT01533415 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CES treatment using Alpha-Stim technology
Description: Treatment involves the passage of micro current levels of electrical stimulation across the head via electrodes placed bilaterally on the ears. The current used in this device is no stronger than the current that naturally occurs in the human body. Treatment is delivered using a current equal to 0.5 Hz for a period of 60 mins. Treatment will be self-administered on a daily basis 5-7 days per week.The manufacturer of the device, Electro medical Products, Inc. will provide the devices for the study. They will alter the functional devices to deliver treatment at a therapeutic level of \<1 mA. The current cannot be altered by the participant. Participants will be required to log the date, time, and duration of treatment. The logs will be provided by the PI and will be collected weekly. Participants will also be required to complete the Hamilton Anxiety Rating Scale (HAM-A) and the Hamilton Depression Rating Scale 17 (HAM-D17) at baseline and at weeks 1, 3, and 5.
Study NCT01533415 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Shame CES Treatment
Description: Treatment will be self-administered on a daily basis 5-7 days per week.The manufacturer of the device, Electro medical Products, Inc. will provide the devices for the study. They will alter the devices so they cannot emit an electrical current. The ability for the device to emit a current cannot be altered by the participant. Participants will be required to log the date, time, and duration of treatment. The logs will be provided by the PI and will be collected weekly. Participants will also be required to complete the Hamilton Anxiety Rating Scale (HAM-A) and the Hamilton Depression Rating Scale 17 (HAM-D17) at baseline and at weeks 1, 3, and 5.
Study NCT02286063 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ambulatory Oxygen
Description: The IMP investigated in this study is medical oxygen (PL 15929/005), manufactured by Air Liquide Ltd. UK. Oxygen is a colourless, odourless gas with molecular weight 32, a boiling point of 183.1°C (at 1 bar) and a density of 1.355 kg/m3 (at 15°C and 1013mb).~Oxygen is present in the atmosphere at 21% and is an absolute necessity for life. Each of the four oxygen companies across the UK provide a light and a standard weight oxygen cylinder. Ambulatory Oxygen will be given to the Oxygen arm.
Study NCT02996578 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: low polyphenol content chocolate bar
Description: Low polyphenol content matched chocolate bar. Each participant will consume 198.5mg of polyphenols
Study NCT02996578 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: low polyphenol content cocoa powder
Description: Low polyphenol content cocoa powder. Each participant will consume 6g containing 191.2mg of polyphenols
Study NCT04639167 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paths to everyday life (PEER)
Description: The intervention consists of a 10-week group course and the opportunity of individual companionship to e.g. local activities in civil society, municipal social services, education, health and employment. The 10-week group sessions are delivered by two volunteer peers with their own experiential knowledge of mental vulnerability and mental health difficulties. The aim is to form a constructive community through group sessions where exchanges of lived experiences, mutuality and opportunities for social network development can develop.
Study NCT02938104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey Protein Isolate Powder
Description: Nutritional counselling is given to patients to ensure their daily proteins and energy requirements are met. Whey Protein Isolate Posder (Immunocal) is provided.~Immunocal (1.5g/kg PO (by mouth) per day in daily doses
Study NCT02938104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey Protein Isolate Powder
Description: Nutritional counselling is given to patients to ensure their daily proteins and energy requirements are met. Whey Protein Isolate Posder (Immunocal) is provided.~Immunocal (1.5g/kg PO (by mouth) per day in daily doses
Study NCT02938104 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Exercise Program
Description: Physical exercises personalized by a kinesiologist consisting of walking or stationary bike and elastic band exercises.
Study NCT02938104 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical Exercise Program
Description: Physical exercises personalized by a kinesiologist consisting of walking or stationary bike and elastic band exercises.
Study NCT02938104 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxation Techniques
Description: Relaxation techniques consisting of breathing exercises and using a relaxation CD
Study NCT02938104 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Techniques
Description: Relaxation techniques consisting of breathing exercises and using a relaxation CD
Study NCT01112358 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: r-FSH
Description: r-FSH will be administered as specified in the arm description.
Study NCT01945424 — intervention group
Intervention type: BIOLOGICAL
Intervention: Quadrivalent Influenza Vaccine (QIV)
Description: No Intervention as part of this protocol
Study NCT04116476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-7117
Description: Single Dose of MT-7117
Study NCT01112358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: r-FSH
Description: r-FSH will be administered as specified in the arm description.
Study NCT01112358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: r-hLH
Description: r-hLH will be administered as specified in the arm description.
Study NCT01112358 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Analogous GnRH antagonist
Description: Analogous GnRH antagonist will be administered as specified in the arm description.
Study NCT02557542 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: One Stop Vein Clinic
Description: Same day diagnosis and treatment
Study NCT02557542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One Stop Vein Clinic
Description: Same day diagnosis and treatment
Study NCT02557542 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency ablation
Description: Venous ablation
Study NCT02557542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Description: Venous ablation
Study NCT02557542 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endovenous laser ablation
Description: Venous ablation
Study NCT01869751 — intervention group
Intervention type: DRUG
Intervention: Prucalopride
Description: Treatment with prucalopride for slow-transit constipation
Study NCT00694954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diagnostic Test - Given Imaging Pillcam
Description: Procedure performed once only after randomization. If procedure is incomplete due to a number of variables, procedure may possibly need to be repeated.~Diagnostic possibilities: normal exam, active bleeding, potential source of bleeding (angiodysplasia, ulcer, tumor)
Study NCT00694954 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diagnostics
Description: Any other diagnostic tests (if not already performed) that the referring or attending physician deems necessary aside from Wireless Capsule Endoscopy.
Study NCT02557542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation
Description: Venous ablation
Study NCT02557542 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Foam sclerotherapy (Polidocanol or Sodium Tetradecyl Sulphate)
Description: Venous ablation
Study NCT02557542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Foam sclerotherapy (Polidocanol or Sodium Tetradecyl Sulphate)
Description: Venous ablation
Study NCT02918409 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colistin
Study NCT02918409 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tobramycin
Study NCT01404026 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Current Stimulation (tDCS)
Description: Subjects will undergo tDCS stimulation. For both active and sham stimulation we will use electrodes at 35cm\^2, with an intensity of 2mA. The anodal electrode will be placed over the primary motor cortex, and the cathode will be placed over the contralateral supraorbital area. For active stimulation, the current will be active for the duration of 20 minutes. For sham stimulation, the current will only be active for 30 seconds, simulating the sensations of active stimulation.
Study NCT01404026 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Direct Current Stimulation (tDCS)
Description: Subjects will undergo tDCS stimulation. For both active and sham stimulation we will use electrodes at 35cm\^2, with an intensity of 2mA. The anodal electrode will be placed over the primary motor cortex, and the cathode will be placed over the contralateral supraorbital area. For active stimulation, the current will be active for the duration of 20 minutes. For sham stimulation, the current will only be active for 30 seconds, simulating the sensations of active stimulation.
Study NCT03134651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Monitoring brain function
Study NCT03637231 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Ultra low-dose CTAC
Description: All patients undergo two non-contrast enhanced CT scans with standard dose (i.e. 120 kVp), one with 80 kVp and one with 70 kVp.
Study NCT02427269 — intervention group
Intervention type: OTHER
Intervention: Specimen Collection
Description: * 1 10mL red tube and 1 8.5mL yellow tube for serum, plasma, and buffy collection~* Up to 10 research-specific biopsies obtained from the esophagus during the routine care EGD.~* Four biopsies will be taken from the midpoint of the current BE (or midpoint of previous BE if the patient has already received ablation for previous BE),~* Two biopsies from normal squamous epithelium, and~* One biopsy from each area of esophageal nodularity seen during the procedure~* Pathology slides from routine care biopsies taken during the enrollment procedure, as well as retrospective pathology slides from routine care biopsies taken prior to enrollment on the study.~* Up to 4 cytology brushes during the procedure.
Study NCT03309488 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Oral food challenge
Description: Patients with suspected food allergy will undergo clinical and dietary assessments and oral food challenge. Different allergy tests will be performed, including skin prick test, specific IgE test and basophil activation test, and its diagnostic utility will be determined against the clinical gold-standard.
Study NCT01151839 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Esophagectomy
Description: Patient with squamous cell carcinoma of esophagus will be treated with surgery alone
Study NCT01151839 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Neoadjuvant chemoradiation followed by surgery
Description: Patient with squamous cell carcinoma of esophagus will be treated by neoadjuvant chemoradiation followed by surgery
Study NCT04738903 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Femtosecond laser assisted LASIK eye surgery
Description: FS-LASIK eye surgery includes corneal flap creation with femtosecond laser using the Femtosecond laser WaveLight FS200 followed by excimer laser vision correction of the patient's refractive error using excimer laser WaveLight EX500.
Study NCT02749318 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: IL-1 genetic test for risk of severe periodontitis
Description: DNA obtained by cheek swab analyzed for four variations (SNPs) in the IL-1beta gene to determine whether patient is at elevated risk for more severe periodontal disease.
Study NCT03057639 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT03057639 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03134651 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol
Study NCT02050763 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The SHARE Project
Description: SHARE aimed to reduce IPV and used methodologies from two proven successful violence prevention frameworks: Stepping Stones (Welbourn, 1995) and the Resource Guide for Mobilizing Communities to Prevent Domestic Violence (Michau \& Naker, 2003). SHARE promoted a process of social change based on the Transtheoretical Model's Stages of Change Theory (Prochaska \& DiClemente, 1983; Prochaska \& Velicer, 1997) which posits that although people realize they need to make changes in their life, they do it in stages instead of one major life change. There are five main stages of change: (1) pre-contemplation, (2) contemplation, (3) preparation for action, (4) action and (5) maintenance.~We hypothesized that repeated exposure to the ideas included in SHARE would encourage men and women to begin a process of change that results in preventive behavior.
Study NCT02076451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-8273a
Description: DS-8273a will be administered as an intravenous (IV) solution. Subjects will receive DS-8273a on Day 1 of a 21 day cycle (once every 3 weeks
Study NCT03117062 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: occlusal reduction
Description: relief of occlusion following endodontic treatment
Study NCT00677690 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: neuromuscular electrical stimulation (NMES)
Description: NMES was applied by means of a commercially available four channel electrostimulator which generated a symmetrical biphasic pulsed current. Each session lasted 30 minutes and was performed 5 days/week for 5 weeks.
Study NCT00677690 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham electrical stimulation
Description: Sham stimulation was performed with the same modality and time, but the stimulus was set up at 5 Hz.
Study NCT02562417 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Study NCT04054843 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Afamin
Description: Plasma maternal afamin levels
Study NCT04484415 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Cevira®
Description: The device is a single-use, disposable, LED-based red light source. The device will automatically switch on the light 5 hours after administration, and provide continuous photoactivation of 125 J/cm2 over 4.6 hours before automatically shutting down.
Study NCT04484415 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo device is identical in appearance as the Cevira® device, but does not provide light.
Study NCT01568918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamsulosin hydrochloride
Description: Participants will receive 0.4 mg/day tamsulosin hydrochloride from 5 days prior to the operation until hospital discharge.
Study NCT01568918 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsule matching the active study drug will be given daily from 5 days prior to the operation until hospital discharge.
Study NCT02641990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ITCA 650 20/60 mcg/day, ITCA placebo
Description: ITCA 650 osmotic mini pump delivering exenatide 20/60 mcg/day and Levora® for 28 days, followed by ITCA osmotic mini pump delivering placebo and Levora® for 28 days
Study NCT02641990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ITCA placebo, ITCA 650 20/60 mcg/day
Description: ITCA osmotic mini pump delivering placebo and Levora® for 28 days, followed by Levora® and ITCA 650 osmotic mini pump delivering exenatide 20/60 mcg/day and Levora® for 28 days
Study NCT04233931 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PrEP medication adherence mobile app
Description: Participants use a PrEP medication adherence mobile app for six weeks.
Study NCT04337307 — intervention group
Intervention type: BIOLOGICAL
Intervention: Skin sampling of the hands of the healthcare workers involved in the decontamination of incubators
Description: Each incubator will be sampled in 5 points before and after decontamination. The healthcare worker that will be involved in the decontamination will also be sampled (skin sample of the hand) before and after decontamination of the incubator.~All the samples will be analyzed for the presence of pathogenic bacteria, using an inoculation on selective agar then an identification of each bacterial colony.
Study NCT02562417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV dexamethasone
Study NCT02521818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Atkins Diet
Study NCT02521818 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NIA Diet for Seniors
Study NCT02631876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirvetuximab soravtansine
Description: Mirvetuximab Soravtansine will be administered per dose and schedule specified in the arm.
Study NCT02631876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered per dose and schedule specified in the arm.